Sort   by:  
 Page size 
UnknownThe TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
Not available
S-EPMC6123489 | biostudies-literature
UnknownSafety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naive Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
Not available
S-EPMC4909487 | biostudies-literature
UnknownA double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.
Not available
S-EPMC6698638 | biostudies-literature
Sort   by:  
 Page size